Literature DB >> 12754254

Sorcin regulates excitation-contraction coupling in the heart.

Marian B Meyers1, Avi Fischer, Yan-Jie Sun, Coeli M B Lopes, Tibor Rohacs, Tomoe Y Nakamura, Ying-Ying Zhou, Paul C Lee, Ruth A Altschuld, Sylvia A McCune, William A Coetzee, Glenn I Fishman.   

Abstract

Sorcin is a penta-EF hand Ca2+-binding protein that associates with both cardiac ryanodine receptors and L-type Ca2+ channels and has been implicated in the regulation of intracellular Ca2+ cycling. To better define the function of sorcin, we characterized transgenic mice in which sorcin was overexpressed in the heart. Transgenic mice developed normally with no evidence of cardiac hypertrophy and no change in expression of other calcium regulatory proteins. In vivo hemodynamics revealed significant reductions in global indices of contraction and relaxation. Contractile abnormalities were also observed in isolated adult transgenic myocytes, along with significant depression of Ca2+ transient amplitudes. Whole cell ICa density and the time course of activation were normal in transgenic myocytes, but the rate of inactivation was significantly accelerated. These effects of sorcin on L-type Ca2+ currents were confirmed in Xenopus oocyte expression studies. Finally, we examined the expression of sorcin in normal and failing hearts from spontaneous hypertensive heart failure rats. In normal myocardium, sorcin extensively co-localized with ryanodine receptors at the Z-lines, whereas in myopathic hearts the degree of co-localization was markedly disrupted. Together, these data indicate that sorcin modulates intracellular Ca2+ cycling and Ca2+ influx pathways in the heart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754254     DOI: 10.1074/jbc.M302009200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.

Authors:  Xi Chen; Craig Weber; Emily T Farrell; Francisco J Alvarado; Yan-Ting Zhao; Ana M Gómez; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-11-22       Impact factor: 5.000

2.  Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells.

Authors:  Angélica Rueda; Ming Song; Ligia Toro; Enrico Stefani; Héctor H Valdivia
Journal:  J Physiol       Date:  2006-08-24       Impact factor: 5.182

3.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

Review 4.  Altered cardiac calcium handling in diabetes.

Authors:  Darrell D Belke; Wolfgang H Dillmann
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

5.  The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load.

Authors:  King-Tung Chin; Guoxin Kang; Jiaxiang Qu; Lawrence B Gardner; William A Coetzee; Ester Zito; Glenn I Fishman; David Ron
Journal:  FASEB J       Date:  2011-04-20       Impact factor: 5.191

6.  Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains.

Authors:  Carlotta Zamparelli; Niall Macquaide; Gianni Colotti; Daniela Verzili; Tim Seidler; Godfrey L Smith; Emilia Chiancone
Journal:  J Mol Cell Cardiol       Date:  2010-03-15       Impact factor: 5.000

7.  Sorcin modulates mitochondrial Ca(2+) handling and reduces apoptosis in neonatal rat cardiac myocytes.

Authors:  Jorge Suarez; Patrick M McDonough; Brian T Scott; Angelica Suarez-Ramirez; Hong Wang; Eduardo S Fricovsky; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-14       Impact factor: 4.249

8.  Complex modulation of L-type Ca(2+) current inactivation by sorcin in isolated rabbit cardiomyocytes.

Authors:  Mark R Fowler; Gianni Colotti; Emilia Chiancone; Yoshiharu Higuchi; Tim Seidler; Godfrey L Smith
Journal:  Pflugers Arch       Date:  2008-09-02       Impact factor: 3.657

9.  Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k.

Authors:  Bryan S Benn; Dare Ajibade; Angela Porta; Puneet Dhawan; Matthias Hediger; Ji-Bin Peng; Yi Jiang; Goo Taeg Oh; Eui-Bae Jeung; Liesbet Lieben; Roger Bouillon; Geert Carmeliet; Sylvia Christakos
Journal:  Endocrinology       Date:  2008-03-06       Impact factor: 4.736

10.  Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.

Authors:  Jeffery A Goldstein; Sasha Bogdanovich; Anastasia Beiriger; Lisa M Wren; Ann E Rossi; Quan Q Gao; Brandon B Gardner; Judy U Earley; Jeffery D Molkentin; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2014-07-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.